SOPHIA WAGNER: Open Payments
NPI 1417683277 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 79 payments from 15 companies in 2025. Trend: 2023 $1,523 · 2024 $1,859 · 2025 $1,907
Food & beverage: $1,707Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $605 |
| GENZYME CORPORATION | 10 | $294 |
| GlaxoSmithKline, LLC. | 17 | $256 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Regeneron Healthcare Solutions, Inc. | 10 | $177 |
| Verona Pharma, Inc. | 3 | $59 |
| Baxter Healthcare | 3 | $56 |
| Grifols USA, LLC | 2 | $53 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Viatris Specialty LLC | 2 | $46 |
Products named: DUPIXENT, TEZSPIRE, Adempas, AIRSUPRA, TRELEGY ELLIPTA, NUCALA, BREZTRI, FASENRA.
Industry payments across LA — which companies pay providers there.
